Forskningsradar
← Alla bevakningsområden

Life Sciences

1736 artiklar · sida 40 av 70

🇸🇪 Endast svenska
4.6

Researchers discovered that a common vaccine additive triggers lasting changes in bone marrow stem cells, boosting the body's general defenses against infections beyond the targeted disease. The finding could reshape vaccine design and improve protection across populations, with significant implications for pharmaceutical development and public health strategy.EN

2026-01-01 · Immunology · , , et al.
4.6

Researchers have identified the optimal settings for BirdNET, a widely-used machine learning tool that listens for bird sounds to track biodiversity. The findings, tested across 67 locations worldwide, provide a practical playbook for conservation groups, environmental consultants, and regulators who rely on automated bird surveys to assess ecosystem health and guide land management decisions.EN

2026-01-01 · IBIS · , , et al.
4.6

A protein called CD5L normally protects joints from severe damage during rheumatoid arthritis, but patients lacking it experience significantly worse outcomes, researchers discovered. The finding could lead to new treatments that restore the protein's function, potentially offering an alternative path for the millions of RA patients who don't respond well to existing drugs.EN

2026-01-01 · MOLECULAR MEDICINE · , , et al.
4.6

Researchers found that HIV attacks nerve cells in the brain within weeks of infection, causing measurable damage that persists even after patients start antiretroviral therapy. The finding suggests earlier, more aggressive treatment strategies could prevent long-term neurological complications that affect quality of life and work productivity.EN

2026-01-01 · The Journal of infectious diseases · , , et al.
4.6

Researchers developed a population-level analysis method that captures the full diversity of protein variations in antibodies and blood proteins, revealing patterns previously hidden by conventional testing. The approach could improve diagnostics, drug development, and monitoring of infections—with applications across therapeutics and biologics manufacturing.EN

2026-01-01 · MABS · , , et al.
4.6

A desert lark species shows dramatic genetic differences when scientists look at mitochondrial DNA versus nuclear DNA, suggesting the two genomes may evolve on completely different timescales. The finding challenges assumptions about how to measure species divergence and could reshape how researchers classify populations and predict conservation outcomes.EN

2026-01-01 · ZOOLOGICA SCRIPTA · , , et al.
4.6

Danish researchers found that a simple blood marker—S100B protein—could identify which traumatic brain injury patients will develop epilepsy. The discovery offers hospitals a potential tool to flag high-risk patients early and guide treatment decisions, addressing a major complication that affects thousands of TBI survivors annually.EN

2026-01-01 · Epilepsia · , , et al.
4.6

Researchers identified a cerebrospinal fluid marker that detects striatal brain deterioration in Huntington's disease patients up to 30 years before symptoms appear. The finding could transform clinical trial design and enable preventive treatments, potentially reshaping the economics of neurodegenerative disease management.EN

2026-01-01 · MOVEMENT DISORDERS · , , et al.
4.6

A Norwegian study tracking 93 hospitalized patients found that 77% showed clinical improvement by 12 months, though 41% still experienced symptoms affecting daily life. The findings matter for public health planning and workplace policies in endemic regions, where lingering fatigue remains the most common long-term complaint.EN

2026-01-01 · EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES · , , et al.
4.6

Researchers found that genetic predisposition to schizophrenia correlates with fewer behavioral symptoms in frontotemporal dementia patients—a finding that could reshape how clinicians assess and treat neuropsychiatric complications in dementia. The discovery, drawn from nearly 7,000 patients across five European cohorts, suggests psychiatric and dementia genetics interact differently depending on disease type, opening new diagnostic and therapeutic pathways.EN

2026-01-01 · INTERNATIONAL REVIEW OF PSYCHIATRY · , , et al.
4.6

Researchers demonstrated that advanced laser imaging can identify porokeratosis—a precancerous skin condition—as accurately as traditional biopsies, potentially eliminating invasive testing. If validated in larger studies, the technique could accelerate diagnosis, reduce healthcare costs, and enable earlier intervention for at-risk patients.EN

2026-01-01 · JEADV CLINICAL PRACTICE · , , et al.
4.6

Researchers used films to map which brain regions activate when people fear being socially excluded—finding the right amygdala lights up during rejection scenarios. The discovery could reshape how entertainment companies design content and help clinicians identify people vulnerable to anxiety disorders.EN

2026-01-01 · Leonardo ·
4.6

Researchers analyzed genetic data from over 3,000 patients undergoing cognitive behavioral therapy for depression and anxiety but found no genetic markers that reliably predict who will improve. The null result suggests treatment response depends more on individual circumstances than inherited biology—reshaping how companies and clinicians should think about personalized mental healthcare.EN

2026-01-01 · American Journal of Medical Genetics Part B · , , et al.
4.6

Researchers have fixed a critical limitation in AlphaFold2 that hindered its use in finding new drugs. By generating multiple structural variations of protein binding sites rather than single snapshots, the improved method doubles down on identifying promising drug candidates—potentially accelerating and cutting costs in the race to develop new medicines.EN

2026-01-01 · Journal of Chemical Information and Modeling · , , et al.
4.6

Researchers identified a compound called AZ7136 that activates HCAR1, a receptor tied to fat burning and blood sugar control. The finding opens a new path for obesity and diabetes treatments, potentially worth billions in the pharmaceutical market if it moves toward clinical use.EN

2026-01-01 · BRITISH JOURNAL OF PHARMACOLOGY · , , et al.
4.6

Researchers found that European pied flycatchers living in oak forests versus nearby pine forests harbor distinctly different gut bacteria—despite living just 1km apart. The discovery suggests that habitat change, whether natural or human-created, fundamentally reshapes the microbial communities that help birds digest food and survive, with implications for conservation and species adaptation to environmental shifts.EN

2026-01-01 · , , et al.
4.6

Lek mellan hundägare och hund stärker den emotionella närheten mellan dem mer effektivt än träning. Forskare vid Linköpings universitet undersökte sambandet mellan lekaktiviteter och relationen mellan hund och ägare genom två studier. I den första studien (n=2940) identifierades signifikanta samband mellan både lek och träning och alla tre mätdimensioner av hundens relationsscala (p<0,0001). I den andra studien tilldelades 408 deltagare tre grupper under fyra veckor: lek, träning eller kontroll. Endast lekgruppen visade signifikant förbättrad emotionell närhet efter behandlingsperioden (p=0,018), vilket påvisar en kausal effekt. Resultaten tyder på att lek har större påverkan än träning för att stärka relationskvaliteten. För aktörer inom hundhälsa och välfärdsmarknad relevanta detta för produktutveckling och rådgivning — vetenskapligt underlag för att rekommendera lek framför träningsfokus kan öka efterfrågan på lekprodukter och välfärdsprogram baserade på detta fynd.

2026-01-01 · Royal Society Open Science · , ,
4.6

FORCE-panelen för SNP-typning visar lovande resultat i rättsmedicinskanalys, men kräver standardisering av laboratorieprotokoll för bred implementering. Linköpings universitet och 14 internationella laboratorier testade fyra tillverkarutvecklade berikningsmetoder på 12 DNA-prover med varierande kvalitet. Alla fyra tillvägagångssätt lyckades producera fullständiga SNP-genotyper från högkvalitativt material. Dock påvisades signifikanta skillnader mellan metoderna — särskilt gällande läsantal och berikningsmetod påverkade anropshastigheten. Robust SNP-återhämtning observerades vid 0,3 ng DNA-input över samtliga metoder, medan amplikonbaserad analys presterade vid så låga halter som 0,03 ng. Fångstmetoder och enkel primärförlängning gav konsekvent höga anropshastigheter från degraderat DNA. Resultaten indikerar att optimering av laboratoriespecifika parametrar kan reducera variation och möjliggöra jämlik adoption av SNP-metoder inom rättsmedicinskanalys.

2026-01-01 · Forensic Science International · , , et al.
4.6

A study of kidney disease patients has identified endostatin, a protein in the bloodstream, as a marker that predicts who will experience rapid disease progression and higher mortality. The finding could help clinicians identify high-risk patients earlier and improve treatment decisions, potentially reducing costly complications and hospitalizations.EN

2026-01-01 · Pulse · , , et al.
4.6

Swedish travelers to Nepal showed rapid increases in potentially harmful gut bacteria during their stay, with changes persisting weeks after returning home. The finding suggests international travel may alter microbiota linked to colorectal cancer development—a concern as CRC rates climb in developing nations and global mobility increases.EN

2025-01-01 · Beneficial Microbes · ,
4.6

A study of nearly 10,000 people reveals that processed red meat consumption shrinks the diversity of gut microbiota—a marker linked to chronic disease risk. The finding could reshape food industry reformulation strategies and influence public health messaging around meat consumption.EN

2025-01-01 · Clinical nutrition (Edinburgh, Scotland) · , , et al.
4.5 🇮🇹 🇸🇪

Forskare vid Sahlgrenska Universitetssjukhuset och Göteborgs universitet kartlade proteinnätverken i hjärtmuskelprover från patienter med två typer av kardial amyloidosö — ATTR och ALλ. Studien identifierade hur ljuskedjefibril förs in i makrofager genom makropinokytoskytning och orsakar mitokondriell toxicitet, samt hur ATTR ansamlas extracellmässigt. Genom proteinkvantiering och nätverkstopologi kunde forskargruppen peka ut potentiella sjukdomsmarkörer. Analyserna utgick från känsligt tillgängligt biopsimaterial från hjärtamyloidospatienter. Även om studien är baserad på robusta urvalskriterier krävs validering i större kohorter. För bolag som utvecklar diagnostik eller läkemedel mot kardial amyloidosö erbjuder dessa molekylära profiler nya angreppspunkter för biomarkörselekton och terapiutveckling inom en marknad med begränsad konkurrens.

2026-07-17 · PubMed · , , et al.
4.5 🇮🇸 🇸🇪

En ny SCN9A-mutation hos isländsk familj öppnar vägen för bättre förståelse av smärtreglering och potentiella läkemedelsmål. En 73-årig man och hans två bröder bär en unik genetisk kombination — en tidigare känd mutation (p.Lys1659Ter) tillsammans med en helt ny deletion (c.417-15_4174-14delAT) som tar bort exon 23 och 18 aminosyror från natriumkanalen. Genom helgenomssekvensering bekräftade forskare vid Sahlgrenska och University of Iceland att denna sammansatt heterozygoti förklarar familjens medfödda smärtokänslighet utan att påverka andra neurologiska funktioner nämnvärt. Fyndet är relevant för läkemedelsutvecklare som söker selektiva SCN9A-hämmare för smärtbehandling. Mutationen visar exakt vilka proteindomäner som är icke-essentiella för normal neurologisk funktion, vilket reducerar risken för biverkningar vid framtida terapier. Denna precision gör studien värdefull för såväl målidentifiering som säkerhetsprofil.

2026-06-01 · PubMed · , , et al.
4.5 🇬🇧 🇸🇪 🇺🇸

Researchers have identified a metabolic approach to reverse mitochondrial damage in a rare genetic form of glaucoma caused by optineurin mutations. The finding could open a new drug development pathway for this blinding disease and potentially inform treatment strategies for other neurodegenerative conditions linked to cellular energy failure.EN

2026-02-19 · Research Square · , , et al.
4.5 🇨🇳 🇸🇪 🇺🇸

Researchers have developed a new class of drugs that hijack lysosomes—the cell's waste-disposal system—to selectively destroy disease-causing proteins and enable combination therapies. The approach could expand treatment options for cancers and other diseases where existing drugs have failed, potentially opening a new market for precision therapeutics.EN

2026-02-18 · Research Square · , , et al.